Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
The team hope the compound –developed after 10 years of painstaking research will be trialled on humans within three to four years.
The drug- which works by targeting Mycobacterium tuberculosis’ defences rather than the bacteria itself – can also take out its increasingly commonly antibiotic resistant strains.
The research funded by the Medical Research Council – is published today in the Journal of Medicinal Chemistry.
Although a vaccine for TB was developed 100 years ago, one in three people across the world are thought to be infected with the infectious disease.
About 1.7 million die from the bug each year worldwide and 7.3 million people were diagnosed and treated in 2018, up from the 6.3 million in 2016.
It is most common in Africa, India and China, but on the rise in the UK with London often described as the TB capital of Europe.
Patients are forced to take a cocktail of strong antibiotics over 6 to 8 months, often enduring unpleasant side effects with a 20% risk that the disease will return.
But now The University of Manchester team’s discovery has been proven effective in guinea pigs at Rutgers University in the United States.
The animals with acute and chronic TB infection were treated with the compound, which was discovered after investigating dozens of other derivatives and compounds thought to have similar properties.
Professor Lydia Tabernero is the project leader. She said: “The fact that the animal studies showed our compound, which doesn’t kill the bacteria directly, resulted in a significant reduction in the bacterial burden is remarkable.
“For more than 60 years, the only weapon doctors have been able to use against TB is antibiotics. But resistance is becoming an increasingly worrying problem and the prolonged treatment is difficult and distressing for patients.
“And with current treatments, there’s no guarantee the disease will be eliminated: antibiotics do not clear the infection and the risk of being infected with drug-resistant bacteria is very high.
“But by disabling this clandestine bacteria’s defences we’re thrilled to find a way that enhances the chances of the body’s immune system to do its job, and thus eliminate the pathogen.”
Mycobacterium Tuberculosis secretes molecules called Virulence Factors – the cell’s secret weapon -which block out the immune response to the infection, making it difficult to treat.
The team identified one Virulence Factor called MptpB as a suitable target, which when blocked allows white blood cells to kill Mycobacterium Tuberculosis in a more efficient way
Professor Tabernero added: “The great thing about MptpB is that there’s nothing similar in humans – so our compound which blocks it is not toxic to the human cells.
“Because the bacteria hasn’t been threatened directly, it is less likely to develop resistance against this new agent, and this will be a major advantage over current antibiotics, for which bacteria had already become resistant.
“TB is an amazingly difficult disease to treat so we feel this is a significant breakthrough.
”The next stage of our research is to optimise further the chemical compound, but we hope clinical trials are up to four years away.”
Learn more: Scientists develop new drug treatment for TB
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Tuberculosis Remains World’s Top Infectious Killer, But A Turning Point May Be Near on September 18, 2018 at 9:58 am
Tuberculosis remains the world’s top infectious killer for the fourth year in a row, the World Health Organization said Tuesday. Despite TB’s lock on the grim title, as it kills far more than HIV/AIDS ... […]
- Nigeria: Global Fund Accuses Nigerian Cso Officials of Misappropriating Millions Donated to Fight Tuberculosis on September 18, 2018 at 9:31 am
Global Fund, an international donor agency, has accused officials of a Nigerian civil society organisation (CSO) of stealing from money meant for their staff salaries. Global Fund to Fight AIDS ... […]
- Negotiated Deal Stands For UN Tuberculosis Declaration on September 18, 2018 at 6:27 am
IP-Watch is a non-profit independent news service and depends on subscriptions. To access all of our content, please subscribe here. You may also offer additional support with your subscription, or do... […]
- The Elders Urge to Intensify Efforts against Tuberculosis on September 17, 2018 at 11:23 am
United Nations, Sep 17 (Prensa Latina) The group of advisers The Elders urged world leaders on Monday to redouble their efforts to eradicate tuberculosis (TB) and attend a summit on the issue at the U... […]
- U.N. finalizes a declaration to combat the global tuberculosis epidemic on September 17, 2018 at 5:58 am
fter a protracted showdown, the United Nations has finalized a declaration to address a global tuberculosis epidemic, an effort that was repeatedly delayed this summer as the U.S. and numerous other c... […]
- Scientists warn of global crisis over failure to tackle tuberculosis on September 15, 2018 at 9:05 am
Patients wait to be tested for tuberculosis at a hospital in Liberia – one of the countries most affected by the disease. Photograph: SOPA Images/LightRocket via Getty Images Heads of state, doctors a... […]
- Is Salvini right to claim tuberculosis is spreading in Italy and blame immigration? | #TheCube on September 13, 2018 at 7:03 pm
Italy’s deputy prime minister Matteo Salvini claims tuberculosis is spreading in Italy and suggests that uncontrolled immigration is to blame. In a Facebook post on Wednesday, the head of the far-righ... […]
- How to prevent, tackle tuberculosis on September 13, 2018 at 5:40 am
Tuberculosis, commonly called TB, is an infectious disease that is caused by a germ or micro bacterium called Mycobacterium tuberculosis. Primarily affecting the lungs, it is a single infectious ... […]
- Ending tuberculosis will take lower drug prices and a new, improved innovation ecosystem on September 13, 2018 at 1:45 am
he United Nations “high-level meeting” on tuberculosis will take place in less than a month and the political declaration that emerges from it will, for better or worse, shape the global response to t... […]
via Bing News